Talphera (TLPH) Total Non-Current Liabilities (2010 - 2026)
Talphera (TLPH) recorded quarterly Total Non-Current Liabilities of $10.5 million in Q1 2026, up 2.1% quarter-over-quarter from $10.3 million in Q4 2025, and up 23.58% on a YoY basis from $8.5 million in Q1 2025.
Talphera (TLPH) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Talphera's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $10.5 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 23.58% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (up 23.58% YoY), while the FY2025 annual figure was $10.3 million, up 12.36% from the prior year.
- Total Non-Current Liabilities was $10.5 million for Q1 2026 at Talphera, up from $10.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $25.6 million in Q1 2022 to a low of $3.6 million in Q3 2023.
- Historically, Total Non-Current Liabilities has averaged $11.7 million across 5 years, with a median of $9.7 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities plunged 82.08% in 2023, then jumped 159.9% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $18.6 million in 2022, then plunged by 75.71% to $4.5 million in 2023, then jumped by 103.32% to $9.2 million in 2024, then climbed by 12.36% to $10.3 million in 2025, then advanced by 2.1% to $10.5 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $10.5 million (Q1 2026), $10.3 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | 10.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.52 Mn |
| Dec 31, 2025 | 10.31 Mn |
| Sep 30, 2025 | 9.71 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.52 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 9.29 Mn |
| Jun 30, 2024 | 9.80 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 7.31 Mn |
| Mar 31, 2023 | 10.26 Mn |
| Dec 31, 2022 | 18.58 Mn |
| Sep 30, 2022 | 19.94 Mn |
| Jun 30, 2022 | 22.14 Mn |
| Mar 31, 2022 | 25.63 Mn |
| Dec 31, 2021 | 28.50 Mn |
| Sep 30, 2021 | 29.30 Mn |
| Jun 30, 2021 | 115.45 Mn |